Most people have put the COVID-19 pandemic behind them. Infections, vaccinations, or a combination of both have bolstered people's immunity, and while new variants continue to pop up, getting sick ...

Brazilian researchers reveal that even mild cases of COVID-19 can temporarily reduce heart rate variability, with stress on the autonomic nervous system lasting up to six months—especially in older ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days ...

"I still have nerve damage in both hands, in both arms." The families of Raul Pero and Titou Phommachahn are glad to have them back home after hard-fought battles against COVID-19. Yet, months after ...

Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced physical performance. A patent-protected tablet (CICR-NAM) developed at the ...

For many people who have “recovered” from COVID-19, the illness lingers as brain fog: forgotten appointments, lost words ...

A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery of COVID-19 patients and reduced mortality. On average, it took eight days ...

About The Study: In this randomized clinical trial of outpatients with mild to moderate COVID-19, treatment with montelukast did not reduce duration of COVID-19 symptoms. These findings do not support ...

When the COVID-19 pandemic hit, health systems across the U.S. canceled elective procedures and transitioned many team members to remote work. New York experienced the peak of COVID-19 cases in April ...